跳至主要内容
临床试验/IRCT20200810048347N1
IRCT20200810048347N1已完成未知

The effect of zinc supplementation on the treatment of neonatal sepsis

Technology and Research Vice-chancellery, Hormozgan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 day 至 28 days(—)
性别
All

入选标准

  • Presence of at least 2 clinical signs of sepsis including pallor or generalized jaundice, cardiovascular manifestations (tachy- or bradycardia, poor perfusion, or shock), change in body temperature (hypo- or hyperthermia), respiratory manifestations (grunting, intercostal retraction, apnea, or cyanosis), neurologic manifestations (hypotonia, lethargy, irritability, or seizure), gastrointestinal symptoms (abdominal distension, hepatosplenomegaly)
  • CRP >5 mg/ml
  • Presence of at least 1 positive serum parameter based on Fanarrof (book) including WBC <5000/microliter or >25000 at birth or WBC>30000 12-24 hours after birth or WBC>21000 on the second day of birth or the following days, absolute neutrophil count (ANC) <1800/microliter, platelet count <150000/microliter, immature/total (I/T) neutrophil ratio <0.16 on the first day and <0.13 from the second day on.
  • Gestational age >37 weeks
  • Age <28 days
  • Informed consent of the parents

排除标准

  • Important congenital anomalies such as trisomies
  • Hypoxic ischemic encephalopathy
  • Intracranial hemorrhage
  • Respiratory distress syndrome
  • Inborn errors of metabolism
  • Candidiasis

研究者

发起方
Technology and Research Vice-chancellery, Hormozgan University of Medical Sciences

相似试验